APO Research

APO RESEARCH · REPORT

Neonatal Intensive Care

Selected research

Market Outlook & Growth Opportunities

Global Neonatal Intensive Care Market Outlook and Growth Opportunities 2026

Market perspective

The global Neonatal Intensive Care market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Neonatal Intensive Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Neonatal Intensive Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Neonatal Intensive Care is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Neonatal Intensive Care market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Neonatal Intensive Care market include Jiangsu Yuyue Medical Equipment and Supply Co., Ltd., Beijing Aeonmed Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Edan Instruments, Inc., Micomme Medical Technology Development Co., Ltd., Guangdong Biolight Meditech Co., Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Ningbo David Medical Device Co., Ltd. and Zhengzhou Dison Instrument and Meter Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Neonatal Intensive Care market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Neonatal Intensive Care and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Neonatal Intensive Care revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Neonatal Intensive Care market.

Neonatal Intensive Care Segment by Company

Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.

Beijing Aeonmed Co., Ltd.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Edan Instruments, Inc.

Micomme Medical Technology Development Co., Ltd.

Guangdong Biolight Meditech Co., Ltd.

Shenzhen Comen Medical Instruments Co., Ltd.

Ningbo David Medical Device Co., Ltd.

Zhengzhou Dison Instrument and Meter Co., Ltd.

GE Healthcare

Philips

Dragerwerk

Getinge

Hamilton

Neonatal Intensive Care Segment by Type

Baby Care Equipment

Ventilator

Monitor

Others

Neonatal Intensive Care Segment by Application

Public Hospital

Private Hospital

Neonatal Intensive Care Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Neonatal Intensive Care status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Neonatal Intensive Care key companies, revenue, market share, and recent developments.

3. To split the Neonatal Intensive Care breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Neonatal Intensive Care market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Neonatal Intensive Care significant trends, drivers, influence factors in global and regions.

6. To analyze Neonatal Intensive Care competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neonatal Intensive Care market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neonatal Intensive Care and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neonatal Intensive Care.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neonatal Intensive Care industry.

Chapter 3: Detailed analysis of Neonatal Intensive Care company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Neonatal Intensive Care in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Neonatal Intensive Care in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Neonatal Intensive Care Industry Trends Table 2. Neonatal Intensive Care Industry Drivers Table 3. Neonatal Intensive Care Industry Opportunities and Challenges Table 4. Neonatal Intensive Care Industry Restraints Table 5. Global Neonatal Intensive Care Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Neonatal Intensive Care Revenue Share by Company (2021-2026) Table 7. Global Neonatal Intensive Care Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Neonatal Intensive Care Key Company Manufacturing Base & Headquarters Table 9. Global Neonatal Intensive Care Company, Product Type & Application Table 10. Global Neonatal Intensive Care Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Neonatal Intensive Care by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Baby Care Equipment Table 15. Significant Companies of Ventilator Table 16. Significant Companies of Monitor Table 17. Significant Companies of Others Table 18. Global Neonatal Intensive Care Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Neonatal Intensive Care Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Neonatal Intensive Care Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Neonatal Intensive Care Sales Value Share by Type (2021-2026) Table 22. Global Neonatal Intensive Care Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Public Hospital Table 24. Significant Companies of Private Hospital Table 25. Global Neonatal Intensive Care Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Neonatal Intensive Care Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Neonatal Intensive Care Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Neonatal Intensive Care Sales Value Share by Application (2021-2026) Table 29. Global Neonatal Intensive Care Sales Value Share by Application (2027-2032) Table 30. Global Neonatal Intensive Care Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Neonatal Intensive Care Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Neonatal Intensive Care Sales Value Share by Region (2021-2026) Table 33. Global Neonatal Intensive Care Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Neonatal Intensive Care Sales Value Share by Region (2027-2032) Table 35. Global Neonatal Intensive Care Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Neonatal Intensive Care Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Neonatal Intensive Care Sales Value Market Share by Country (2021-2026) Table 38. Global Neonatal Intensive Care Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Neonatal Intensive Care Sales Value Market Share by Country (2027-2032) Table 40. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Company Information Table 41. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Business Overview Table 42. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Neonatal Intensive Care Product Portfolio Table 44. Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Recent Development Table 45. Beijing Aeonmed Co., Ltd. Company Information Table 46. Beijing Aeonmed Co., Ltd. Business Overview Table 47. Beijing Aeonmed Co., Ltd. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Beijing Aeonmed Co., Ltd. Neonatal Intensive Care Product Portfolio Table 49. Beijing Aeonmed Co., Ltd. Recent Development Table 50. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Information Table 51. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Business Overview Table 52. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Neonatal Intensive Care Product Portfolio Table 54. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Development Table 55. Edan Instruments, Inc. Company Information Table 56. Edan Instruments, Inc. Business Overview Table 57. Edan Instruments, Inc. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Edan Instruments, Inc. Neonatal Intensive Care Product Portfolio Table 59. Edan Instruments, Inc. Recent Development Table 60. Micomme Medical Technology Development Co., Ltd. Company Information Table 61. Micomme Medical Technology Development Co., Ltd. Business Overview Table 62. Micomme Medical Technology Development Co., Ltd. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Micomme Medical Technology Development Co., Ltd. Neonatal Intensive Care Product Portfolio Table 64. Micomme Medical Technology Development Co., Ltd. Recent Development Table 65. Guangdong Biolight Meditech Co., Ltd. Company Information Table 66. Guangdong Biolight Meditech Co., Ltd. Business Overview Table 67. Guangdong Biolight Meditech Co., Ltd. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Guangdong Biolight Meditech Co., Ltd. Neonatal Intensive Care Product Portfolio Table 69. Guangdong Biolight Meditech Co., Ltd. Recent Development Table 70. Shenzhen Comen Medical Instruments Co., Ltd. Company Information Table 71. Shenzhen Comen Medical Instruments Co., Ltd. Business Overview Table 72. Shenzhen Comen Medical Instruments Co., Ltd. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Shenzhen Comen Medical Instruments Co., Ltd. Neonatal Intensive Care Product Portfolio Table 74. Shenzhen Comen Medical Instruments Co., Ltd. Recent Development Table 75. Ningbo David Medical Device Co., Ltd. Company Information Table 76. Ningbo David Medical Device Co., Ltd. Business Overview Table 77. Ningbo David Medical Device Co., Ltd. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Ningbo David Medical Device Co., Ltd. Neonatal Intensive Care Product Portfolio Table 79. Ningbo David Medical Device Co., Ltd. Recent Development Table 80. Zhengzhou Dison Instrument and Meter Co., Ltd. Company Information Table 81. Zhengzhou Dison Instrument and Meter Co., Ltd. Business Overview Table 82. Zhengzhou Dison Instrument and Meter Co., Ltd. Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Zhengzhou Dison Instrument and Meter Co., Ltd. Neonatal Intensive Care Product Portfolio Table 84. Zhengzhou Dison Instrument and Meter Co., Ltd. Recent Development Table 85. GE Healthcare Company Information Table 86. GE Healthcare Business Overview Table 87. GE Healthcare Neonatal Intensive Care Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. GE Healthcare Neonatal Intensive Care Product Portfolio Table 89. GE Healthcare Recent Development Table 90. Philips Company Information Table 91. Philips Business Overview Table 92. Philips Neonatal Intensive Care Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Philips Neonatal Intensive Care Product Portfolio Table 94. Philips Recent Development Table 95. Dragerwerk Company Information Table 96. Dragerwerk Business Overview Table 97. Dragerwerk Neonatal Intensive Care Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Dragerwerk Neonatal Intensive Care Product Portfolio Table 99. Dragerwerk Recent Development Table 100. Getinge Company Information Table 101. Getinge Business Overview Table 102. Getinge Neonatal Intensive Care Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Getinge Neonatal Intensive Care Product Portfolio Table 104. Getinge Recent Development Table 105. Hamilton Company Information Table 106. Hamilton Business Overview Table 107. Hamilton Neonatal Intensive Care Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Hamilton Neonatal Intensive Care Product Portfolio Table 109. Hamilton Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Neonatal Intensive Care Product Image Figure 2. Global Neonatal Intensive Care Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neonatal Intensive Care Market Size (2021-2032) & (US$ Million) Figure 4. Global Neonatal Intensive Care Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Baby Care Equipment Image Figure 8. Ventilator Image Figure 9. Monitor Image Figure 10. Others Image Figure 11. Global Neonatal Intensive Care Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Neonatal Intensive Care Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Neonatal Intensive Care Sales Value Share by Type (2021-2032) Figure 14. Public Hospital Image Figure 15. Private Hospital Image Figure 16. Global Neonatal Intensive Care Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Neonatal Intensive Care Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Neonatal Intensive Care Sales Value Share by Application (2021-2032) Figure 19. Global Neonatal Intensive Care Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Neonatal Intensive Care Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Neonatal Intensive Care Sales Value (2021-2032) & (US$ Million) Figure 22. North America Neonatal Intensive Care Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Neonatal Intensive Care Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Neonatal Intensive Care Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Neonatal Intensive Care Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Neonatal Intensive Care Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Neonatal Intensive Care Sales Value (2021-2032) & (US$ Million) Figure 28. South America Neonatal Intensive Care Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Neonatal Intensive Care Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Neonatal Intensive Care Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Neonatal Intensive Care Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Baby Care Equipment
  • Ventilator
  • Monitor
  • Others
Applications
  • Public Hospital
  • Private Hospital
Companies covered
  • Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.
  • Beijing Aeonmed Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Edan Instruments, Inc.
  • Micomme Medical Technology Development Co., Ltd.
  • Guangdong Biolight Meditech Co., Ltd.
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • Ningbo David Medical Device Co., Ltd.
  • Zhengzhou Dison Instrument and Meter Co., Ltd.
  • GE Healthcare
  • Philips
  • Dragerwerk
  • Getinge
  • Hamilton

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Neonatal Intensive Care Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Neonatal Intensive Care Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Neonatal Intensive Care Market Dynamics
  1. 2.1 Neonatal Intensive Care Industry Trends
  2. 2.2 Neonatal Intensive Care Industry Drivers
  3. 2.3 Neonatal Intensive Care Industry Opportunities and Challenges
  4. 2.4 Neonatal Intensive Care Industry Restraints
3 Neonatal Intensive Care Market by Company
  1. 3.1 Global Neonatal Intensive Care Company Revenue Ranking in 2025
  2. 3.2 Global Neonatal Intensive Care Revenue by Company (2021-2026)
  3. 3.3 Global Neonatal Intensive Care Company Ranking (2024-2026)
  4. 3.4 Global Neonatal Intensive Care Company Manufacturing Base and Headquarters
  5. 3.5 Global Neonatal Intensive Care Company Product Type and Application
  6. 3.6 Global Neonatal Intensive Care Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Neonatal Intensive Care Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Neonatal Intensive Care Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Neonatal Intensive Care Market by Type
  1. 4.1 Neonatal Intensive Care Type Introduction
  2. 4.1.1 Baby Care Equipment
  3. 4.1.2 Ventilator
  4. 4.1.3 Monitor
  5. 4.1.4 Others
  6. 4.2 Global Neonatal Intensive Care Sales Value by Type
  7. 4.2.1 Global Neonatal Intensive Care Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Neonatal Intensive Care Sales Value by Type (2021-2032)
  9. 4.2.3 Global Neonatal Intensive Care Sales Value Share by Type (2021-2032)
5 Neonatal Intensive Care Market by Application
  1. 5.1 Neonatal Intensive Care Application Introduction
  2. 5.1.1 Public Hospital
  3. 5.1.2 Private Hospital
  4. 5.2 Global Neonatal Intensive Care Sales Value by Application
  5. 5.2.1 Global Neonatal Intensive Care Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Neonatal Intensive Care Sales Value by Application (2021-2032)
  7. 5.2.3 Global Neonatal Intensive Care Sales Value Share by Application (2021-2032)
6 Neonatal Intensive Care Regional Value Analysis
  1. 6.1 Global Neonatal Intensive Care Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Neonatal Intensive Care Sales Value by Region (2021-2032)
  3. 6.2.1 Global Neonatal Intensive Care Sales Value by Region: 2021-2026
  4. 6.2.2 Global Neonatal Intensive Care Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Neonatal Intensive Care Sales Value (2021-2032)
  7. 6.3.2 North America Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Neonatal Intensive Care Sales Value (2021-2032)
  10. 6.4.2 Europe Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Neonatal Intensive Care Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Neonatal Intensive Care Sales Value (2021-2032)
  16. 6.6.2 South America Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Neonatal Intensive Care Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Neonatal Intensive Care Sales Value Share by Country, 2025 VS 2032
7 Neonatal Intensive Care Country-level Value Analysis
  1. 7.1 Global Neonatal Intensive Care Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Neonatal Intensive Care Sales Value by Country (2021-2032)
  3. 7.2.1 Global Neonatal Intensive Care Sales Value by Country (2021-2026)
  4. 7.2.2 Global Neonatal Intensive Care Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Neonatal Intensive Care Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Neonatal Intensive Care Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Neonatal Intensive Care Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd.
  2. 8.1.1 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Company Information
  3. 8.1.2 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Business Overview
  4. 8.1.3 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Neonatal Intensive Care Product Portfolio
  6. 8.1.5 Jiangsu Yuyue Medical Equipment and Supply Co., Ltd. Recent Developments
  7. 8.2 Beijing Aeonmed Co., Ltd.
  8. 8.2.1 Beijing Aeonmed Co., Ltd. Company Information
  9. 8.2.2 Beijing Aeonmed Co., Ltd. Business Overview
  10. 8.2.3 Beijing Aeonmed Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Aeonmed Co., Ltd. Neonatal Intensive Care Product Portfolio
  12. 8.2.5 Beijing Aeonmed Co., Ltd. Recent Developments
  13. 8.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  14. 8.3.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Company Information
  15. 8.3.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Business Overview
  16. 8.3.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Neonatal Intensive Care Product Portfolio
  18. 8.3.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Developments
  19. 8.4 Edan Instruments, Inc.
  20. 8.4.1 Edan Instruments, Inc. Company Information
  21. 8.4.2 Edan Instruments, Inc. Business Overview
  22. 8.4.3 Edan Instruments, Inc. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Edan Instruments, Inc. Neonatal Intensive Care Product Portfolio
  24. 8.4.5 Edan Instruments, Inc. Recent Developments
  25. 8.5 Micomme Medical Technology Development Co., Ltd.
  26. 8.5.1 Micomme Medical Technology Development Co., Ltd. Company Information
  27. 8.5.2 Micomme Medical Technology Development Co., Ltd. Business Overview
  28. 8.5.3 Micomme Medical Technology Development Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Micomme Medical Technology Development Co., Ltd. Neonatal Intensive Care Product Portfolio
  30. 8.5.5 Micomme Medical Technology Development Co., Ltd. Recent Developments
  31. 8.6 Guangdong Biolight Meditech Co., Ltd.
  32. 8.6.1 Guangdong Biolight Meditech Co., Ltd. Company Information
  33. 8.6.2 Guangdong Biolight Meditech Co., Ltd. Business Overview
  34. 8.6.3 Guangdong Biolight Meditech Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Biolight Meditech Co., Ltd. Neonatal Intensive Care Product Portfolio
  36. 8.6.5 Guangdong Biolight Meditech Co., Ltd. Recent Developments
  37. 8.7 Shenzhen Comen Medical Instruments Co., Ltd.
  38. 8.7.1 Shenzhen Comen Medical Instruments Co., Ltd. Company Information
  39. 8.7.2 Shenzhen Comen Medical Instruments Co., Ltd. Business Overview
  40. 8.7.3 Shenzhen Comen Medical Instruments Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shenzhen Comen Medical Instruments Co., Ltd. Neonatal Intensive Care Product Portfolio
  42. 8.7.5 Shenzhen Comen Medical Instruments Co., Ltd. Recent Developments
  43. 8.8 Ningbo David Medical Device Co., Ltd.
  44. 8.8.1 Ningbo David Medical Device Co., Ltd. Company Information
  45. 8.8.2 Ningbo David Medical Device Co., Ltd. Business Overview
  46. 8.8.3 Ningbo David Medical Device Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ningbo David Medical Device Co., Ltd. Neonatal Intensive Care Product Portfolio
  48. 8.8.5 Ningbo David Medical Device Co., Ltd. Recent Developments
  49. 8.9 Zhengzhou Dison Instrument and Meter Co., Ltd.
  50. 8.9.1 Zhengzhou Dison Instrument and Meter Co., Ltd. Company Information
  51. 8.9.2 Zhengzhou Dison Instrument and Meter Co., Ltd. Business Overview
  52. 8.9.3 Zhengzhou Dison Instrument and Meter Co., Ltd. Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Zhengzhou Dison Instrument and Meter Co., Ltd. Neonatal Intensive Care Product Portfolio
  54. 8.9.5 Zhengzhou Dison Instrument and Meter Co., Ltd. Recent Developments
  55. 8.10 GE Healthcare
  56. 8.10.1 GE Healthcare Company Information
  57. 8.10.2 GE Healthcare Business Overview
  58. 8.10.3 GE Healthcare Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  59. 8.10.4 GE Healthcare Neonatal Intensive Care Product Portfolio
  60. 8.10.5 GE Healthcare Recent Developments
  61. 8.11 Philips
  62. 8.11.1 Philips Company Information
  63. 8.11.2 Philips Business Overview
  64. 8.11.3 Philips Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Philips Neonatal Intensive Care Product Portfolio
  66. 8.11.5 Philips Recent Developments
  67. 8.12 Dragerwerk
  68. 8.12.1 Dragerwerk Company Information
  69. 8.12.2 Dragerwerk Business Overview
  70. 8.12.3 Dragerwerk Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dragerwerk Neonatal Intensive Care Product Portfolio
  72. 8.12.5 Dragerwerk Recent Developments
  73. 8.13 Getinge
  74. 8.13.1 Getinge Company Information
  75. 8.13.2 Getinge Business Overview
  76. 8.13.3 Getinge Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Getinge Neonatal Intensive Care Product Portfolio
  78. 8.13.5 Getinge Recent Developments
  79. 8.14 Hamilton
  80. 8.14.1 Hamilton Company Information
  81. 8.14.2 Hamilton Business Overview
  82. 8.14.3 Hamilton Neonatal Intensive Care Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hamilton Neonatal Intensive Care Product Portfolio
  84. 8.14.5 Hamilton Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research